<DOC>
	<DOCNO>NCT02111603</DOCNO>
	<brief_summary>The investigator ' hypothesis therapy Colesevelam , reduce fecal bile acid excretion patient Irritable Bowel Syndrome ( IBS ) -diarrhea prior evidence increase fecal 48 hour total bile acid excretion . The investigator aim study ability HPLC assay fecal bile acid demonstrate responsiveness treatment Colesevelam .</brief_summary>
	<brief_title>Ability Mayo Clinic High-performance Liquid Chromatography ( HPLC ) Method Measure Fecal Bile Acids</brief_title>
	<detailed_description>This study evaluate whether Colesevelam , bile acid sequestrant , able reduce fecal bile acid improve bowel function patient IBS-diarrhea Mayo 's HPLC method demonstrate response Colesevelam . The study design single center , unblinded , single dose trial study ability identify effect take 1875 mg ( 3 tablet [ 625 mg/tablet ] ) Colesevelam orally twice daily ten day fast serum 7alphaC4 total 48 hour fecal bile acid excretion . Stool fast serum sample collect predose final 48 hour ' dose assessment . Participants also fill 8-day stool diary assessing frequency , consistency , ease passage bowel movement treatment Colesevelam .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Patients IBSdiarrhea prior evidence increase fecal 48 hour total bile acid increase fast serum 7alphaC4 meet following : INCLUSION CRITERIA Bowel disease questionnaire ( BDQ ) IBS symptom : Positive Rome lll criterion No restriction Hospital Anxiety/Depression Score ( HADS ) . Gender : Men woman . Women childbearing potential negative pregnancy test initiation medication . EXCLUSION CRITERIA Use drug agent within past 1 week plan use subsequent 2 week study period ( Birth control pill , estrogen replacement therapy , thyroxine replacement permissible exception ) : Agents alter GI transit include opioids , narcotic , anticholinergic , tricyclic antidepressant , serotoninnorepinephrine reuptake inhibitor ( SNRI ) antidepressant . Analgesic drug include opiate , nonsteroidal antiinflammatory drug ( NSAID ) , cyclooxygenase2 ( COX 2 ) inhibitor Intake medication could interfere interpretation study . Female subject pregnant breastfeeding . Females must either surgically sterilize , postmenopausal ( &gt; 12 month since last menses ) , , childbearing potential , use reliable method contraception determine physician . Abdominal surgery ( except Appendectomy ) Patients know chronic liver disease history elevate aspartate aminotransferase ( AST ) / alanine transaminase ( ALT ) 2.0 X upper limit normal . Bile acid ( BA ) synthesis possible false positive negative fecal bile acid serum 7alphahydroxy4cholesten3one ( 7alphaC4 ) result . If AST ALT value medical record , study physician determine test need run .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>